New Alzheimer’s drug is first of its kind to be FDA approved
(NEW YORK) -- In a major development for patients and the biotechnology industry, the US Food and Drug Administration approved the use of a new drug, Aduhelm (aducanumab), for treating early Alzheimer’s disease.
According to the Alzheimer’s Association, over 5 million Americans have Alzheimer’s disease... Read More.
